Streetbeat News

Analyst Ratings

REED

Roth MKM analyst Sean McGowan maintains a 'Buy' rating on Reed's (OTC:REED) but has lowered the price target from $17 to $7.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 1:53 pm

BRTX

Roth MKM analyst Jonathan Aschoff has reiterated a 'Buy' rating on BioRestorative Therapies (NASDAQ:BRTX), maintaining a price target of $15.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 1:51 pm

MNTX

Roth MKM analyst Matt Koranda has reiterated a 'Buy' rating on Manitex International (NASDAQ:MNTX) and maintained an $8 price target.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 1:50 pm

GO

Roth MKM analyst Bill Kirk maintains a Neutral rating on Grocery Outlet Holding (NASDAQ:GO) and raises the price target from $29 to $31.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 1:48 pm

SNA

Roth MKM analyst Scott Stember has reiterated a 'Buy' rating on Snap-on (NYSE:SNA) and maintained a price target of $324.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 1:47 pm

AGNPF

ATAI

PSIL

The American Psychedelic Practitioners Association and BrainFutures have published the first-ever professional practice guidelines for psychedelic-assisted therapy. Algernon NeuroScience, a subsidiary of Algernon Pharmaceuticals, has finalized its clinical trial design for a phase 2 DMT stroke study. Atai Life Sciences, MindMed, and COMPASS Pathways have reported their Q2 2023 financial results. AdvisorShares Psychedelics ETF has seen a decrease in its weekly performance.

Portfolio Pulse from Lara Goldstein

August 14, 2023 | 1:47 pm

ASLN

Roth MKM analyst Dylan Dupuis has reiterated a 'Buy' rating on ASLAN Pharma (NASDAQ:ASLN) and maintained a price target of $15.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 1:46 pm

MPC

A significant bearish stance has been taken on Marathon Petroleum (NYSE:MPC) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split between 40% bullish and 60% bearish. The whales have been targeting a price range from $115.0 to $150.0 for Marathon Petroleum over the last 3 months. The current price of MPC is $149.12, down by 0.42%. Analysts from Wells Fargo, RBC Capital, Barclays, Raymond James, and Morgan Stanley have maintained their ratings on MPC, with price targets ranging from $140 to $165.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 1:46 pm

AMSC

Roth MKM analyst Justin Clare maintains a 'Buy' rating on American Superconductor (NASDAQ:AMSC) and raises the price target from $7 to $10.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 1:45 pm

MNTX

Northland Capital Markets has initiated coverage on Manitex International (NASDAQ:MNTX) with an Outperform rating and a price target of $10.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 1:40 pm